Switching patterns of immediate-release forms of generic mixed amphetamine salts products among privately and publicly insured individuals ages 15-64 years in the United States, 2013-2019.

These descriptive analyses, although subject to limitations, did not suggest increased switching away or switching back after use of the generics of interest. Continued post-marketing surveillance is warranted. This article is protected by copyright. All rights reserved.